| Recruitment status | Completed |
| Unique ID issued by UMIN | UMIN000016142 |
| Receipt No. | R000018741 |
| Scientific Title | Mindfulness-based cognitive therapy for patients with cancer |
| Date of disclosure of the study information | 2015/01/07 |
| Last modified on | 2020/07/11 (Ver. 9) |
| Basic information | ||
| Public title | Mindfulness-based cognitive therapy for patients with cancer | |
| Acronym | MBCT for cancer patients | |
| Scientific Title | Mindfulness-based cognitive therapy for patients with cancer | |
| Scientific Title:Acronym | MBCT for cancer patients | |
| Region |
|
|
| Condition | ||||||
| Condition | cancer | |||||
| Classification by specialty |
|
|||||
| Classification by malignancy | Malignancy | |||||
| Genomic information | NO | |||||
| Objectives | |
| Narrative objectives1 | To test efficacy of mindfulness-based cognitive therapy for depression, anxiety and fatigue in patients with cancer. |
| Basic objectives2 | Efficacy |
| Basic objectives -Others | |
| Trial characteristics_1 | Confirmatory |
| Trial characteristics_2 | |
| Developmental phase | Phase III |
| Assessment | |
| Primary outcomes | Depression and anxiety, measured by Hospital Anxiety and Depression Scale (HADS) |
| Key secondary outcomes | QoL: Functional Assessment of Cancer Therapy- General(FACT-G)
Spiriuality: Functional Assessment of Cancer Therapy- Spiritual Well-Being(FACIT-Sp) State of mindfulness: Five Facet Mindfulness Questionnaire(FFMQ) Fear of cancer recurrence and progression: Concerns about Recurrence Scale-J(CARS-J) Fatigue: Brief Fatigue Inventory Health utility score: EuroQoL-5 (EQ-5D) Salivary amylase concentration |
| Base | |
| Study type | Interventional |
| Study design | |
| Basic design | Parallel |
| Randomization | Randomized |
| Randomization unit | Individual |
| Blinding | Open -but assessor(s) are blinded |
| Control | No treatment |
| Stratification | |
| Dynamic allocation | |
| Institution consideration | Institution is not considered as adjustment factor. |
| Blocking | YES |
| Concealment | Central registration |
| Intervention | ||
| No. of arms | 2 | |
| Purpose of intervention | Treatment | |
| Type of intervention |
|
|
| Interventions/Control_1 | Mindfulness-based cognitive therapy group intervention | |
| Interventions/Control_2 | Wait-list control | |
| Interventions/Control_3 | ||
| Interventions/Control_4 | ||
| Interventions/Control_5 | ||
| Interventions/Control_6 | ||
| Interventions/Control_7 | ||
| Interventions/Control_8 | ||
| Interventions/Control_9 | ||
| Interventions/Control_10 | ||
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Male and Female | |||
| Key inclusion criteria | 1.Patients with stage 0 - III breast cancer
2.ECOG Performance Status of 0 to 2 3.Hospital Anxiety and Depression Scale >= 5 4.Clinical prognosis of one year or over 5.Willing to participate MBCT program for more than five sessions 6.Submission of written informed consent |
|||
| Key exclusion criteria | 1.Severe physical or mental symptoms which hamper study participation
2.Past experience of MBCT or MBSR 3.Judgement of primary care provider as ineligible for the study |
|||
| Target sample size | 88 | |||
| Research contact person | |||||||
| Name of lead principal investigator |
|
||||||
| Organization | Keio University | ||||||
| Division name | Faculty of Nursing and Medical Care | ||||||
| Zip code | 160-8582 | ||||||
| Address | 35 Shinanomachi, Shinjuku-ku, Tokyo, Japan | ||||||
| TEL | 03-3353-1211 | ||||||
| spak@sfc.keio.ac.jp | |||||||
| Public contact | |||||||
| Name of contact person |
|
||||||
| Organization | Keio University | ||||||
| Division name | School of Medicine | ||||||
| Zip code | 160-8582 | ||||||
| Address | 35 Shinanomachi, Shinjuku-ku, Tokyo, Japan | ||||||
| TEL | 03-3353-1211 | ||||||
| Homepage URL | |||||||
| dfujisawa@keio.jp | |||||||
| Sponsor | |
| Institute | Keio University |
| Institute | |
| Department | |
| Funding Source | |
| Organization | Ministry of Education, Culture, Sports, Science and Technology |
| Organization | |
| Division | |
| Category of Funding Organization | Japanese Governmental office |
| Nationality of Funding Organization | |
| Other related organizations | |
| Co-sponsor | |
| Name of secondary funder(s) | |
| IRB Contact (For public release) | |
| Organization | Ethical Committee, Keio University School of Medicine |
| Address | 35 Shinanomachi, Shinjuku-ku, Tokyo, Japan |
| Tel | 03-3353-1211 |
| med-rinri-jimu@adst.keio.ac.jp | |
| Secondary IDs | |
| Secondary IDs | NO |
| Study ID_1 | |
| Org. issuing International ID_1 | |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | 慶應義塾大学病院(東京都) |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Related information | |
| URL releasing protocol | https://www.ctr.med.keio.ac.jp/rinri/ |
| Publication of results | Partially published |
| Result | |||||||
| URL related to results and publications | https://pubmed.ncbi.nlm.nih.gov/32105790/ | ||||||
| Number of participants that the trial has enrolled | 74 | ||||||
| Results | Significant improvement in depression, anxiety, fear or cancer recurrence, spiritual wellbeing, quality of life and fatigue. |
||||||
| Results date posted |
|
||||||
| Results Delayed | |||||||
| Results Delay Reason | |||||||
| Date of the first journal publication of results |
|
||||||
| Baseline Characteristics | Patients with Stage I-III Breast Cancer |
||||||
| Participant flow | Randomized controlled trial with wait-list control |
||||||
| Adverse events | Participants' subjective symptoms |
||||||
| Outcome measures | Hospital Anxiety and Depression Scale Concerns about Recurrence Scare Functional Assessment of Chronic Illness Therapy Spiritual Wellbeing Scale Functional Assessment of Cancer Therapy General Brief Fatigue Inventory Five Facet Mindfulness Questionnaire |
||||||
| Plan to share IPD | |||||||
| IPD sharing Plan description | |||||||
| Progress | |||||||
| Recruitment status | Completed | ||||||
| Date of protocol fixation |
|
||||||
| Date of IRB |
|
||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date |
|
||||||
| Date of closure to data entry | |||||||
| Date trial data considered complete | |||||||
| Date analysis concluded | |||||||
| Other | |
| Other related information | https://pubmed.ncbi.nlm.nih.gov/32105790/ |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://upload.umin.ac.jp/cgi-open-bin/icdr_e/ctr_view.cgi?recptno=R000018741 |